001367.SZ
Zhejiang Haisen Pharmaceutical Co., Ltd.
SZSE · C 制造业 · CN
CNY 20.44
−6.24%Margins
Gross margin
46.4%
EBITDA margin
34.4%
EBIT margin
29.6%
Net margin
25.6%
FCF margin
9.4%
8.8%
Return on equity
8.2%
Return on assets
10.1%
Return on invested capital
0.32x
Asset turnover
CNY 163.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026